U.S. market Closed. Opens in 1 hour 6 minutes

BFRI | Biofrontera Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue34.07M28.67M24.10M18.85M26.18M
Cost of Revenue18.51M15.19M12.74M9.07M12.41M
Gross Profit15.56M13.49M11.36M9.78M13.77M
Operating Expenses36.91M35.87M37.21M18.12M28.70M
Selling, General & Admin36.84M35.87M37.21M18.12M28.70M
Research & Development77.00KN/AN/AN/AN/A
Other Operating Expenses131.00K33.00K689.00K1.25M5.48M
Operating Income-21.35M-22.38M-25.85M-8.33M-14.92M
Other Expenses / Income1.24M21.77M-11.81M-2.59M3.97M
Before Tax Income-20.12M-608.00K-37.66M-10.92M-10.95M
Income Tax Expenses14.00K32.00K56.00K64.00K33.00K
Net Income-20.13M-640.00K-37.71M-10.99M-10.98M
Interest Expenses600.00K195.00K344.00K2.90M2.16M
Basic Shares Outstanding1.55M1.06M855.24K580.00K607.00K
Diluted Shares Outstanding1.55M1.06M855.24K580.00K607.00K
EBITDA-20.29M-21.18M-25.16M-6.49M-8.75M
EBITDA Margin-59.55%-73.85%-104.41%-34.44%-33.44%
EBIT-19.52M-413.00K-37.31M-8.03M-8.79M
EBIT Margin-57.28%-1.44%-154.83%-42.58%-33.57%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙